Filing Flows › Materials › Arq (ARQ)
Arq (ARQ) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Arq (ARQ) Q3 2026 earnings results →
Q3 2026 Revenue up 9% year over year to $38.2M · 7¢ of every $1 of revenue kept as net profit · operating margin 8.2%
Arq made $38.2M in Q3 2026 (+9% Y/Y). Operating margin 8.2%, net earnings $2.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $38.2M in Q3 2026, up 9% year over year and up 28% from the previous quarter.
Operating profit was $3.1M, a 8.2% margin (up 11.2 points year over year). Total costs fell 3% while revenue rose 9%. The fastest-growing cost line was SG&A (+55%). Net earnings were $2.5M. The effective tax rate was 0.0%.
Operating cash flow was $10.3M (up 95% year over year), 413% of net earnings. Non-cash charges added back $4.1M of depreciation and amortization and $1.2M of share-based compensation. Working capital and other items added $2.5M. Capital expenditures of $780K left free cash flow of $9.6M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $38.2M | +9% | 8.2% | $2.5M | $10.3M |
| Q2 2026 | 10-Q | Aug 10, 2026 | $29.9M | +4% | -0.2% | −$733K | −$2.7M |
| Q1 2026 | 10-Q | May 6, 2026 | $29.1M | +7% | -3.4% | −$842K | $64K |
| Q4 2025 | 10-K | Mar 10, 2026 | $29.4M | +9% | -174.1% | −$50.0M | −$2.8M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $35.1M | +0.9% | -2.4% | −$653K | $5.3M |
| Q2 2025 | 10-Q | Aug 11, 2025 | $28.6M | +12% | -5.4% | −$2.1M | $527K |
| Q1 2025 | 10-Q | May 7, 2025 | $27.2M | +25% | 2.4% | $203K | −$5.8M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Arq
Arq, Inc., together with its consolidated subsidiaries ("Arq", the "Company," "we," "us", or "our") is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions, primarily based on activated carbon ("AC"). Our proprietary AC products enable customers to reduce air, water, and soil contaminants, including mercury, per - and polyfluoroalkyl substances ("PFAS") and other pollutants, to meet the challenges of existing and pending air quality and water regulations. We manufacture and sell AC and other chemicals used to capture and remove impurities, contaminants and pollutants for the coal-fired power generation, industrial, water treatment, and water and soil remediation markets, which we collectively refer to as the advanced purification technologies ("APT") market.
In its own words, from its 10-K, filed Mar 10, 2026.
Arq against its Miscellaneous Chemical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +9% against the peers' median +9%. Operating margin: 8.2% against the peers' median 8.2%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ARQ Arq | Q3 2026 | $38.2M | +9% | 8.2% |
| CBT Cabot | Q4 FY26 | $1.0B | +12% | 12.0% |
| ESI Element Solutions | Q3 2026 | $995M | +52% | 11.4% |
| OEC Orion S.A. | Q3 2026 | $473M | +5% | 4.8% |
| WDFC WD 40 | Q4 FY26 | $177M | +8% | 10.8% |
| FTK Flotek Industries | Q3 2026 | $114M | +104% | 15.7% |
| FSI Flexible Solutions International | Q2 2026 | $7.6M | -33% | -29.2% |
| ASPI ASP Isotopes | Q2 2026 | $5.1M | +328% | -667.5% |
| PURE Pure Bioscience | Q4 FY26 | $659K | -14% | -76.3% |
Source: Arq 10-Q on SEC EDGAR · CIK 1515156 · Miscellaneous Chemical Products
Guidance and outlook
13F: who owns ARQ and who is buying
More on ARQ
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results